Home / Inspections / 1210113

FDA Inspection 1210113 — Carter Bloodcare - Denton

Carter Bloodcare - Denton — FEI 3004853345

The FDA completed an inspection of Carter Bloodcare - Denton on June 15, 2023 in Denton, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 15, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Denton, TX (United States)

Facility

Other inspections at this facility

  • 1066196 (NAI Wed Sep 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983201 (NAI Mon Aug 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 891629 (NAI Wed Jul 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 799644 (NAI Thu Sep 20 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 675928 (NAI Thu Aug 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources